Yes, I think combo is priority number 1. So they want that submitted first, maybe with the new fda twist, they will do it different, but here is NP in the conference.

Quote:

---

15:00 so that we will follow through but we
15:03 are working on our pivotal trial and
15:05 once we submit our first part of our BLA
15:07 which is already complete
15:09 one third of a non-clinical section then
15:12 we will follow with our protocol for a
15:15 mono therapy pivotal trial s

Read More: https://investorshangout.com/post/view?id=536...z5hW4SA6ID

---